Company Art Promopharm Srl with Fiscal Code 30611448
recorded a turnover of 2024 of
454.727,
with a net profit of
278.128
and having an average number of employees of
2.
The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Art Promopharm Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
333.362
244.184
129.613
195.850
300.627
218.220
246.424
311.149
368.935
454.727
Total Income - EUR
341.653
247.813
141.149
196.344
301.398
220.106
247.195
312.920
395.807
454.864
Total Expenses - EUR
218.234
191.073
143.867
133.707
154.288
90.830
80.008
143.353
152.583
163.367
Gross Profit/Loss - EUR
123.419
56.740
-2.717
62.638
147.110
129.276
167.187
169.568
243.223
291.497
Net Profit/Loss - EUR
103.606
47.903
-4.094
60.679
144.536
127.670
165.106
166.820
240.219
278.128
Employees
2
2
2
2
2
2
2
2
2
2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 23.9%, from 368.935 euro in the year 2023, to 454.727 euro in 2024.
The Net Profit increased by 39.251 euro, from 240.219 euro in 2023, to 278.128 in the last year.
Check the financial reports for the company - Art Promopharm Srl
Financial Rating - ART PROMOPHARM SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Art Promopharm Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Art Promopharm Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Art Promopharm Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Art Promopharm Srl - CUI 30611448
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
5.241
70.695
52.531
35.902
16.955
4.193
2.858
694
121.733
88.975
Current Assets
228.872
96.182
48.043
26.689
130.396
121.347
158.328
168.406
129.013
390.810
Inventories
3.141
3.112
3.177
3.059
3.013
2.794
2.732
2.750
2.742
12.046
Receivables
62.187
63.686
32.486
10.352
77.298
99.705
121.503
117.086
111.698
198.971
Cash
163.544
29.384
12.379
13.278
50.086
18.848
34.093
48.569
14.573
179.793
Shareholders Funds
218.818
155.291
93.266
59.038
144.587
127.719
165.154
166.868
247.616
278.176
Social Capital
45
45
44
43
42
41
40
41
40
40
Debts
17.834
13.008
8.867
6.299
5.655
3.226
4.252
3.228
10.722
203.979
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4646 - 4646"
CAEN Financial Year
4619
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
390.810 euro in 2024 which includes Inventories of
12.046 euro, Receivables of
198.971 euro and cash availability of
179.793 euro.
The company's Equity was valued at
278.176 euro, while total Liabilities amounted to
203.979 euro.
Equity increased by 31.944 euro, from 247.616 euro in 2023, to 278.176 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Art Promopharm Srl